Introduction 63 64
Fetal growth restriction (FGR) is defined as a neonatal birth-weight less than 10 th 65 percentile for gestation together with evidence of fetal welfare compromise such as 66 reduced amniotic fluid volume, increased head to abdomen circumference ratio and 67 abnormal umbilical artery blood flow patterns [1] . FGR greatly increases the risk of 68 perinatal complications including: fetal compromise in labour, fetal death in utero, 69 neonatal morbidity and neonatal death [2] [3] [4] . Placental insufficiency may result from various factors including: constriction of the 77 placental blood vessels due to reduction in vasodilator activity [12] , incomplete 78 cytotrophoblastic invasion of the maternal spiral arteries [13] or maldevelopment of the 79 placental villous structures [14] . These factors result in increased resistance to blood 80 flow within the placenta in both the maternal and fetal circulations, ultimately resulting in 81 fetal hypoxia and acidosis. 82 83
Normal pregnancy represents a hypercoagulable state characterised by profound 84 changes in haemostasis, such as, increased concentration of pro-coagulant factors, 85 decreased anticoagulant activity and diminished fibrinolytic activity [15] . These changes 86 result in increased thrombin generation in maternal plasma and ultimately, increased 87 fibrin formation. These changes in haemostasis ensure the rapid and effective control of 88 bleeding at the time of placental separation during delivery [15] . On the other hand, 89 these changes may also predispose pregnant women to thrombosis and placental 90 vascular complications. Despite this, thrombotic events are rare in uncomplicated 91 pregnancies [16] , indicating that thrombin generation must be tightly regulated in this 92 scenario. In contrast, histological examinations of placentae from FGR pregnancies 93 demonstrate increased fibrin deposition and thrombi in the vasculature, including 94 uteroplacental and intervillous thrombosis, perivillous fibrin deposits and villous stem 95 artery thrombosis [16] , indicating an increase in overall thrombin activation [17] . The 96 cause of the coagulation disturbance and increased placental thrombosis observed in 97 idiopathic FGR pregnancies is unknown. However, since thrombin generation is 98 significantly increased during normal pregnancy compared to the non-pregnant state 99
[18], the excess thrombin is likely to be generated predominantly by the placenta, as 100 demonstrated by decreased thrombin generation following placental separation during 101 delivery [19] . 102 103
Proteoglycans (PGs) are macromolecules comprising a core protein and at least one 104 negatively charged polysaccharide glycosaminoglycan (GAG) side chain. The small 105 leucine-rich proteoglycan (SLRP) family constitutes a network of signal regulation: being 106 mostly extracellular, they are upstream of multiple signalling cascades, a major conduit 107 M A N U S C R I P T A C C E P T E D HMVECs were transfected with a NC control and siRNA3 and the "Human Growth 266
Factors" Taqman PCR array was used to identify potential downstream target genes of 267 DCN. The relative mRNA expression of the 84 genes after DCN mRNA and protein 268 down-regulation is shown in Fig 3. The Y-axis represents the fold change for each of the 269 M A N U S C R I P T Another plausible explanation for the diverse functions of DCN is that small leucine-rich 363 proteoglycans undergo a dimer-monomer transition that would expose key sites 364 involved in specific bindings; therefore their functional activity in vivo would be regulated 365 by the structure of DCN in that particular cell type and by the intrinsic affinity of DCN for 366 M A N U S C R I P T A C C E P T E D Placental syndecan expression is altered in human idiopathic fetal growth restriction. 
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